Locally Advanced Solid Tumors
Showing 1 - 25 of >10,000
Solid Tumor Trial (Disitamab vedotin)
Not yet recruiting
- Solid Tumor
- Disitamab vedotin
- (no location specified)
Jul 10, 2023
Locally Advanced Solid Tumors, Recurrent Solid Tumors, Metastatic Solid Tumors Trial (RO7566802, Atezolizumab)
Not yet recruiting
- Locally Advanced Solid Tumors
- +2 more
- (no location specified)
Sep 4, 2023
Advanced Solid Tumor Trial in United States (KD033 for Injection)
Recruiting
- Solid Tumor
- KD033 (SAR445710)
-
Santa Monica, California
- +3 more
Jan 23, 2023
Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Edmonton ([131]I-IAZA)
Withdrawn
- Locally Advanced Solid Tumors
- Metastatic Solid Tumors
-
Edmonton, Alberta, CanadaCross Cancer Institute
Jul 7, 2022
Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Los Angeles, Houston (RX108)
Recruiting
- Locally Advanced Solid Tumors
- Metastatic Solid Tumors
-
Los Angeles, California
- +1 more
Apr 12, 2022
Solid Tumors Trial (IBR854 Cell Injection)
Not yet recruiting
- Solid Tumors
- IBR854 Cell Injection
- (no location specified)
Aug 14, 2023
Locally Advanced or Metastatic Solid Tumors Trial in Guangzhou (Drug: BC3195 for Injection)
Recruiting
- Locally Advanced or Metastatic Solid Tumors
- Drug: BC3195 for Injection
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Jul 20, 2023
Solid Tumors, Head Neck Cancer Trial in Shijiazhuang (SYH2051 tablets, Intensity-Modulated Radiation Therapy (IMRT))
Recruiting
- Solid Tumors
- Head and Neck Cancer
- SYH2051 tablets
- Intensity-Modulated Radiation Therapy (IMRT)
-
Shijiazhuang, Hebei, ChinaClinical Trials Information Group
Aug 21, 2023
Locally Advanced or Metastatic Solid Tumors Trial in Guangzhou, Shanghai, Hangzhou (SM3321)
Recruiting
- Locally Advanced or Metastatic Solid Tumors
-
Guangzhou, Guangdong, China
- +2 more
Oct 17, 2023
Locally Advanced or Metastatic Solid Tumors Trial in Beijing (MSC-IFNa, Nab paclitaxel, Cyclophosphamide)
Recruiting
- Locally Advanced or Metastatic Solid Tumors
- MSC-IFNα
- +3 more
-
Beijing, ChinaDepartment of Biotherapeutic, Chinese PLA General Hospital
Jan 29, 2023
Solid Tumor Trial in Sydney (IBI129)
Not yet recruiting
- Solid Tumor
-
Sydney, New South Wales, AustriaSt George private Hospital
Aug 6, 2023
Solid Tumors Trial in Waratah (IBI334)
Not yet recruiting
- Solid Tumors
-
Waratah, New South Wales, AustraliaWestmead Hospital
Mar 7, 2023
Her2-positive/Low-expression Urinary and Digestive Tract Tumors Trial in Beijing (BL-M07D1)
Not yet recruiting
- Her2-positive/Low-expression Urinary and Digestive Tract Tumors
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
Sep 8, 2023
Locally Advanced or Metastatic Digestive Tract Tumors and Other Solid Tumors Trial in Shanghai (BL-M07D1)
Recruiting
- Locally Advanced or Metastatic Digestive Tract Tumors and Other Solid Tumors
-
Shanghai, Shanghai, ChinaFudan University ShangHai Cancer Center
Jan 11, 2023
Solid Tumor, Adult Trial in Beijing (TY-2699a)
Not yet recruiting
- Solid Tumor, Adult
-
Beijing, Beijing, ChinaNational Cancer Center/Cancer Hospital, Chinese Academy of Medic
May 18, 2023
Locally Advanced or Metastatic Urinary Tumors, Other Solid Tumors Trial in Beijing (BL-B01D1)
Recruiting
- Locally Advanced or Metastatic Urinary Tumors
- Other Solid Tumors
-
Beijing, Beijing, China
- +3 more
Jan 11, 2023
Urinary System Tumor, Solid Tumor Trial in Shanghai (BL-B01D1)
Not yet recruiting
- Urinary System Tumor
- Solid Tumor
-
Shanghai, Shanghai, ChinaFudan University ShangHai Cancer Center
Mar 26, 2023
Advanced Solid Tumor Trial in Shanghai (RC118, Toripalimab)
Recruiting
- Advanced Solid Tumor
-
Shanghai, Chinahongshan Hospital Affiliated to Fudan University
Sep 14, 2023
NSCLC, Breast Cancer, HNSCC Trial in Chang chun (YL202 should be intravenously infused)
Not yet recruiting
- NSCLC
- +3 more
- YL202 should be intravenously infused
-
Chang chun, Jilin, ChinaJilin Provincial Cancer Hospital
Oct 25, 2023
Carcinoma Trial (Intravenous infusion anti-CEA-CAR-T cell)
Not yet recruiting
- Carcinoma
- Intravenous infusion anti-CEA-CAR-T cell
- (no location specified)
Aug 22, 2023